cd33 Search Results


cd33 microbeads  (Miltenyi Biotec)
95
Miltenyi Biotec cd33 microbeads
Cd33 Microbeads, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pm36808484-49-15-18?v=Miltenyi+Biotec
Average 95 stars, based on 1 article reviews
cd33 microbeads - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier
gene exp cd33 hs01076282 g1  (Thermo Fisher)
94
Thermo Fisher gene exp cd33 hs01076282 g1
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Gene Exp Cd33 Hs01076282 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pmc13087446-102-26-2?v=Thermo+Fisher
Average 94 stars, based on 1 article reviews
gene exp cd33 hs01076282 g1 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
rh siglec3 cd33 fc chimera  (R&D Systems)
93
R&D Systems rh siglec3 cd33 fc chimera
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Rh Siglec3 Cd33 Fc Chimera, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pm34715394-87-6-21?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
rh siglec3 cd33 fc chimera - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier
fitc cd33 antibody  (Miltenyi Biotec)
94
Miltenyi Biotec fitc cd33 antibody
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Fitc Cd33 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pmc04682915-40-48-52?v=Miltenyi+Biotec
Average 94 stars, based on 1 article reviews
fitc cd33 antibody - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
resource source identifier antibodies cd107a bd pharmingentm  (Miltenyi Biotec)
93
Miltenyi Biotec resource source identifier antibodies cd107a bd pharmingentm
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Resource Source Identifier Antibodies Cd107a Bd Pharmingentm, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pm35784645-151-2-13?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
resource source identifier antibodies cd107a bd pharmingentm - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier
anti siglec 3 cd33 antibody  (R&D Systems)
93
R&D Systems anti siglec 3 cd33 antibody
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Anti Siglec 3 Cd33 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pmc12764780-113-18-23?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
anti siglec 3 cd33 antibody - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier
biotin conjugated clone rea852 miltenyi biotec  (Miltenyi Biotec)
93
Miltenyi Biotec biotin conjugated clone rea852 miltenyi biotec
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Biotin Conjugated Clone Rea852 Miltenyi Biotec, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pm33831365-303-99-103?v=Miltenyi+Biotec
Average 93 stars, based on 1 article reviews
biotin conjugated clone rea852 miltenyi biotec - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier
anti cd33  (Bio-Rad)
93
Bio-Rad anti cd33
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Anti Cd33, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/us07226748-1961-13-16?v=Bio-Rad
Average 93 stars, based on 1 article reviews
anti cd33 - by Bioz Stars, 2026-06
93/100 stars
  Buy from Supplier
anti cd33  (R&D Systems)
94
R&D Systems anti cd33
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Anti Cd33, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/bio_rxiv__64898__2026__03__25__714104-264-74-78?v=R%26D+Systems
Average 94 stars, based on 1 article reviews
anti cd33 - by Bioz Stars, 2026-06
94/100 stars
  Buy from Supplier
biotinylated human siglec  (ACROBiosystems)
95
ACROBiosystems biotinylated human siglec
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Biotinylated Human Siglec, supplied by ACROBiosystems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pmc08449984-41-18-22?v=ACROBiosystems
Average 95 stars, based on 1 article reviews
biotinylated human siglec - by Bioz Stars, 2026-06
95/100 stars
  Buy from Supplier
recombinant human cd33 flag  (OriGene)
90
OriGene recombinant human cd33 flag
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Recombinant Human Cd33 Flag, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pmc05049355-417-29-32?v=OriGene
Average 90 stars, based on 1 article reviews
recombinant human cd33 flag - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
set 4  (Novus Biologicals)
90
Novus Biologicals set 4
Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for <t>CD33</t> , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.
Set 4, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd33/pmc07002223-22-0-5?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
set 4 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for CD33 , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.

Journal: Exploration of Targeted Anti-tumor Therapy

Article Title: Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

doi: 10.37349/etat.2026.1002365

Figure Lengend Snippet: Time-course changes in mRNA expression of immune cell markers in urine. ΔCt values (relative to GAPDH ) for CD33 , PD-L1 ( CD274 ), PD-L2 ( PDCD1LG2 ), and CD204 ( MSR1 ) in urine sediment collected at four time points: before TURBT, before BCG induction, immediately after completion of six BCG instillations, and 3 months after BCG. CD33 increased immediately after BCG and remained elevated for 3 months, whereas CD204 significantly increased after BCG. PD-L1 and PD-L2 showed significant increases immediately after BCG treatment, with PD-L2 returning to baseline by 3 months. P values were obtained from paired Wilcoxon signed-rank tests versus the pre-TURBT baseline. ns: not significant; * P < 0.05; ** P < 0.01; *** P < 0.001. TURBT: transurethral resection of bladder tumor; BCG: Bacillus Calmette–Guérin.

Article Snippet: TaqMan assays (Thermo Fisher Scientific, Waltham, MA, USA) quantified PD-L1 ( CD274 ; assay ID: Hs00204257_m1), PD-L2 ( PDCD1LG2 ; assay ID: Hs00228839_m1), CD33 (assay ID: Hs01076282_g1), CD204 ( MSR1 ; assay ID: Hs00234007_m1), PD-1 ( PDCD1 ; assay ID: Hs0001550088_m1), CTLA4 (assay ID: Hs00175480_m1), FOXP3 (assay ID: Hs01085834_m1), CD3E (assay ID: Hs01062241_m1), CD14 (assay ID: Hs02621496_s1), CD25 (assay ID: Hs0158122_m1), CD11b ( ITGAM ; assay ID: Hs00167304_m1), and Elastase-1 (assay ID: Hs00204m1) in technical triplicates and were normalized to GAPDH .

Techniques: Expressing

Urinary microbiome-immune coupling. Matrix plot summarizing associations between immune-related gene expression (PD-L1 , PD-L2 , CD33 , and CD204 ) and microbiome indices, including phylum-level balances (Bal_) and taxon-specific log-abundances (_nb), across all four time points. Colors indicate the direction and magnitude of the mixed-effects model coefficient ( β ), and numbers in each cell show β (two significant digits). Coefficients ( β ) are from linear mixed-effects models with immune transcript levels (ΔCt) as outcomes and microbiome features as predictors, including a random intercept for participant. Taxon-specific features (nb) were entered as clr-transformed abundances (pseudocount = 1), whereas balance indices (Bal) were entered as predefined log-ratio/ilr features; fixed effects included timepoint and available clinical covariates (age, sex, antibiotics, UTI, stage, maintenance BCG). The symbol † indicates associations that met the exploratory false discovery rate threshold (Benjamini–Hochberg adjusted q < 0.10). Bal_ denotes the log-ratio between two taxonomic groups, and _nb denotes the log-abundance of a specific taxon. Bal_inflam = log[P/(F + B)]. P: Proteobacteria; F: Firmicutes; B: Bacteroidetes; A: Actinobacteria; Cory: Corynebacterium ; Staph: Staphylococcus ; Entero: Enterobacteriaceae; BCG: Bacillus Calmette–Guérin; UTI: urinary tract infection. The underlying numerical results ( β , P , and q values) are provided in .

Journal: Exploration of Targeted Anti-tumor Therapy

Article Title: Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

doi: 10.37349/etat.2026.1002365

Figure Lengend Snippet: Urinary microbiome-immune coupling. Matrix plot summarizing associations between immune-related gene expression (PD-L1 , PD-L2 , CD33 , and CD204 ) and microbiome indices, including phylum-level balances (Bal_) and taxon-specific log-abundances (_nb), across all four time points. Colors indicate the direction and magnitude of the mixed-effects model coefficient ( β ), and numbers in each cell show β (two significant digits). Coefficients ( β ) are from linear mixed-effects models with immune transcript levels (ΔCt) as outcomes and microbiome features as predictors, including a random intercept for participant. Taxon-specific features (nb) were entered as clr-transformed abundances (pseudocount = 1), whereas balance indices (Bal) were entered as predefined log-ratio/ilr features; fixed effects included timepoint and available clinical covariates (age, sex, antibiotics, UTI, stage, maintenance BCG). The symbol † indicates associations that met the exploratory false discovery rate threshold (Benjamini–Hochberg adjusted q < 0.10). Bal_ denotes the log-ratio between two taxonomic groups, and _nb denotes the log-abundance of a specific taxon. Bal_inflam = log[P/(F + B)]. P: Proteobacteria; F: Firmicutes; B: Bacteroidetes; A: Actinobacteria; Cory: Corynebacterium ; Staph: Staphylococcus ; Entero: Enterobacteriaceae; BCG: Bacillus Calmette–Guérin; UTI: urinary tract infection. The underlying numerical results ( β , P , and q values) are provided in .

Article Snippet: TaqMan assays (Thermo Fisher Scientific, Waltham, MA, USA) quantified PD-L1 ( CD274 ; assay ID: Hs00204257_m1), PD-L2 ( PDCD1LG2 ; assay ID: Hs00228839_m1), CD33 (assay ID: Hs01076282_g1), CD204 ( MSR1 ; assay ID: Hs00234007_m1), PD-1 ( PDCD1 ; assay ID: Hs0001550088_m1), CTLA4 (assay ID: Hs00175480_m1), FOXP3 (assay ID: Hs01085834_m1), CD3E (assay ID: Hs01062241_m1), CD14 (assay ID: Hs02621496_s1), CD25 (assay ID: Hs0158122_m1), CD11b ( ITGAM ; assay ID: Hs00167304_m1), and Elastase-1 (assay ID: Hs00204m1) in technical triplicates and were normalized to GAPDH .

Techniques: Gene Expression, Transformation Assay, Infection